Annual Current Liabilities
$39.45 M
+$24.71 M+167.63%
31 December 2023
Summary:
NKGen Biotech Common Stock annual total current liabilities is currently $39.45 million, with the most recent change of +$24.71 million (+167.63%) on 31 December 2023. NKGN annual current liabilities is now -29.23% below its all-time high of $55.74 million, reached on 31 December 2021.NKGN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$51.41 M
+$13.93 M+37.15%
30 June 2024
Summary:
NKGen Biotech Common Stock quarterly total current liabilities is currently $51.41 million, with the most recent change of +$13.93 million (+37.15%) on 30 June 2024. Over the past year, it has increased by +$12.56 million (+32.33%). NKGN quarterly current liabilities is now at all-time high.NKGN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKGN Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +167.6% | +32.3% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
NKGN Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.2% | +167.6% | at high | +248.7% |
| 5 y | 5 years | -29.2% | +167.6% | at high | +248.7% |
| alltime | all time | -29.2% | +167.6% | at high | +248.7% |
NKGen Biotech Common Stock Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $51.41 M(+37.2%) |
| Mar 2024 | - | $37.48 M(-5.0%) |
| Dec 2023 | $39.45 M | $39.45 M(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $38.85 M(+67.2%) |
| June 2023 | - | $23.23 M(+57.6%) |
| Dec 2022 | $14.74 M(-73.6%) | $14.74 M |
| Dec 2021 | $55.74 M | - |
FAQ
- What is NKGen Biotech Common Stock annual total current liabilities?
- What is the all time high annual current liabilities for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock annual current liabilities year-on-year change?
- What is NKGen Biotech Common Stock quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock quarterly current liabilities year-on-year change?
What is NKGen Biotech Common Stock annual total current liabilities?
The current annual current liabilities of NKGN is $39.45 M
What is the all time high annual current liabilities for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high annual total current liabilities is $55.74 M
What is NKGen Biotech Common Stock annual current liabilities year-on-year change?
Over the past year, NKGN annual total current liabilities has changed by +$24.71 M (+167.63%)
What is NKGen Biotech Common Stock quarterly total current liabilities?
The current quarterly current liabilities of NKGN is $51.41 M
What is the all time high quarterly current liabilities for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high quarterly total current liabilities is $51.41 M
What is NKGen Biotech Common Stock quarterly current liabilities year-on-year change?
Over the past year, NKGN quarterly total current liabilities has changed by +$12.56 M (+32.33%)